14 results
424B5
QLGN
Qualigen Therapeutics Inc
1 Dec 21
Prospectus supplement for primary offering
2:28pm
pharmaceuticals and therapeutics industries depends upon its ability to attract, retain and motivate highly skilled and experienced personnel with scientific
10-KT
QLGN
Qualigen Therapeutics Inc
31 Mar 21
Annual report (with FYE transition)
4:33pm
and operations teams.
Our ability to compete depends upon our ability to attract, retain and motivate highly skilled and experienced personnel
424B5
0pvl8 uuyd
18 Dec 20
Prospectus supplement for primary offering
1:26pm
424B5
jsp81jx
2 Oct 20
Prospectus supplement for primary offering
4:24pm
424B5
53n pt8yvslceve
4 Aug 20
Prospectus supplement for primary offering
6:16am
424B5
phlfy9lufnuigqel
10 Jul 20
Prospectus supplement for primary offering
2:35pm
424B3
mgbnb8
9 Apr 20
Prospectus supplement
9:30am
S-4/A
pgb0q
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4
u831uoh
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
- Prev
- 1
- Next